This year's Heart Rhythm meeting, held May 10-13 in Chicago, featured an avalanche of new clinical data on device therapies to treat cardiac arrhythmias and prevent sudden cardiac death, highlighted by data on new leadless devices.
The late-breaking trial presentations at the meeting were headlined by the post-market studies for Medtronic PLC's Micra transcatheter single-chamber pacing system and Boston Scientific Corp.'s S-ICD subcutaneous implantable...